University of Arizona researchers have developed a new therapy for Alzheimer’s disease designed to restore cognitive function in early-stage patients. The therapy, University of Arizona Health Sciences Center for Innovation in Brain Science, is now proceeding through a Phase 2b clinical trial and has been licensed to startup NeuTherapeutics, Inc. 

From July 1, 2020 through June 30, 2021, the university achieved a record 124 license agreements, launched 17 new companies, and grew the number of inventions disclosed and patents filed.

A new study, published in the journal Cell Reports, found that the stiffness of the breast tumor microenvironment can cause changes to cancer cells that make them more aggressively spread to bone. The concept of a “mechanical memory” or “MeCo score” that describes this aggressiveness has driven the foundation of startup MeCo Diagnostics, LLC. 

University of Arizona startup Paramium Technologies, founded to commercialize a precision metal plate forming technology invented by researchers in the Steward Observatory, has demonstrated how a small company can achieve big things with the support of a strong innovation ecosystem.

The new ranking represents continued growth for UArizona. In 2020, a total of 81 patents were issued to UArizona and the Arizona Board of Regents for inventions developed at the university, 19 more than the previous year.